Lilly weekly diabetes drug as effective as market leader Victoza-study

[riky]

Lilly weekly diabetes drug as effective as market leader Victoza-study

An experimental once-weekly medicine for type 2 diabetes developed by Eli Lilly and Co proved as effective in lowering blood sugar as Victoza from Danish drugmaker Novo Nordisk in an eagerly anticipated late stage study. The Lilly drug, dulaglutide, achieved the primary goal of the 599-patient study by demonstrating so-called non-inferiority to the highest approved dose of Victoza after 26 weeks, according to initial results released by the company on Tuesday. Lilly shares rose more than 1 percent before retreating. Dulaglutide, considered one of the more important medicines in Lilly's pipeline of drugs in development, is awaiting U.S. and European approval decisions.

Source: You are not allowed to view links. Register or Login